ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted attack on lingering leukemia cells
Disease control OngoingThis study is testing whether a targeted drug called inotuzumab ozogamicin can eliminate trace amounts of cancer cells that remain in adults with a type of acute lymphocytic leukemia (ALL) after their first round of chemotherapy. The goal is to see if this treatment can help prev…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Frozen donor marrow tested as lifeline for blood cancer patients
Disease control TerminatedThis study aimed to test the safety and effectiveness of a bone marrow transplant for adults with certain blood cancers. The transplant would use frozen bone marrow tissue from unrelated, partially matched deceased donors. After the transplant, patients would take medications lon…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Boosted stem cells aim to speed recovery in aggressive blood cancers
Disease control OngoingThis study is testing whether specially grown cord blood stem cells can help patients with high-risk blood cancers recover their immune systems faster after a transplant. Participants receive a transplant using these expanded stem cells after strong chemotherapy. Researchers are …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test 'Booster Pill' to supercharge Cancer-Fighting cells
Disease control OngoingThis study is testing if taking an oral drug called duvelisib after receiving CAR-T cell therapy can help the engineered immune cells survive longer in the body and work better. It will involve about 42 adults with certain types of lymphoma or leukemia who are already scheduled t…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists reprogram Patient's own cells to hunt blood cancer
Disease control OngoingThis is an early-stage safety study testing a new type of treatment for patients whose B-cell lymphoma or leukemia has returned or not responded to standard therapies. Doctors take a patient's own immune cells (T cells), genetically modify them in a lab to better recognize and at…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC